Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice

Overview of attention for article published in Critical Care, January 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 4 tweeters

patent: 3 patents

Citations

dimensions_citation: 83 Dimensions

Readers on

mendeley: 64 Mendeley

Summary Twitter Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

NOGAPENDEKIN ALFA-INBAKICEPT FOR IMMUNE STIMULANT THERAPIES AND TREATMENT OF VIRAL…

Application WO-2020231855-A1

World Intellectual Property Organisation (WIPO)

BIFIDOBACTERIUM LONGUM ABLE TO BENEFICIALLY MODULATE IMMUNE RESPONSE TO RESPIRATORY VIRUS…

Application WO-2018158309-A1

World Intellectual Property Organisation (WIPO)

BIFIDOBACTERIUM LONGUM ABLE TO BENEFICIALLY MODULATE IMMUNE RESPONSE TO RESPIRATORY VIRUS…

Application WO-2018158306-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.